tiprankstipranks
Trending News
More News >
EPITOMEE MEDICAL LTD (IL:EPIT)
:EPIT
Israel Market
Advertisement

Epitomee Med (EPIT) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Epitomee Med has a market cap or net worth of 239.30M. The enterprise value is ―.
Market Cap239.30M
Enterprise Value

Share Statistics

Epitomee Med has 30,062,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,062,870
Owned by Insiders
Owned by Institutions

Financial Efficiency

Epitomee Med’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -18.01%.
Return on Equity (ROE)-0.16
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-18.01%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee0.00
Profits Per Employee-34.86K
Employee Count42
Asset Turnover0.00
Inventory Turnover104.57

Valuation Ratios

The current PE Ratio of Epitomee Med is 146.9. Epitomee Med’s PEG ratio is 9.89.
PE Ratio146.9
PS Ratio0.00
PB Ratio8.16
Price to Fair Value8.16
Price to FCF-21.47
Price to Operating Cash Flow-0.15
PEG Ratio9.89

Income Statement

In the last 12 months, Epitomee Med had revenue of 0.00 and earned -5.32M in profits. Earnings per share was -0.18.
Revenue0.00
Gross Profit-1.67M
Operating Income-7.28M
Pretax Income-5.32M
Net Income-5.32M
EBITDA-5.74M
Earnings Per Share (EPS)-0.18

Cash Flow

In the last 12 months, operating cash flow was -28.38M and capital expenditures -17.59M, giving a free cash flow of -45.97M billion.
Operating Cash Flow-28.38M
Free Cash Flow-45.97M
Free Cash Flow per Share-1.53

Dividends & Yields

Epitomee Med pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.82
52-Week Price Change-13.38%
50-Day Moving Average838.60
200-Day Moving Average892.99
Relative Strength Index (RSI)46.44
Average Volume (3m)18.42K

Important Dates

Epitomee Med upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Epitomee Med as a current ratio of 9.00, with Debt / Equity ratio of 12.80%
Current Ratio9.00
Quick Ratio8.99
Debt to Market Cap<0.01
Net Debt to EBITDA2.13
Interest Coverage Ratio-9.89

Taxes

In the past 12 months, Epitomee Med has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Epitomee Med EV to EBITDA ratio is -46.11, with an EV/FCF ratio of -20.52.
EV to Sales0.00
EV to EBITDA-46.11
EV to Free Cash Flow-20.52
EV to Operating Cash Flow-31.94

Balance Sheet

Epitomee Med has 18.28M in cash and marketable securities with 4.49M in debt, giving a net cash position of 13.79M billion.
Cash & Marketable Securities18.28M
Total Debt4.49M
Net Cash13.79M
Net Cash Per Share0.46
Tangible Book Value Per Share1.14

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Epitomee Med is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis